A new biodegradable copolymer of glycolic acid and lactones with relatively low molecular weight prepared by direct copolycondensation in the absence of catalysts
Authors:
- 1 March 1991
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research
- Vol. 25 (3) , 315-328
Abstract
Relatively low‐molecular‐weight copolyesters of glycolic acid (GA) with lactones such as γ‐butyrolactone (BL), δ‐valerolactone (VL), and ϵ‐caprolactone (CL) were synthesized by copolycondensation without catalysts. The resulting copolyesters are intended as carriers for drug delivery systems. Copolyesters with approximately 85 mol% GA (number‐average molecular weight (Mn): 2900 ± 100) are crystalline and solid and show a parabolic‐type in vivo degradation pattern. The in vivo degradation of amorphous‐pasty poly (GA/CL) (approximately 50/50 mol%) changed from parabolic‐type to lineartype to S‐type pattern as their molecular weight increased. A luteinizing hormonereleasing hormone agonist, D‐Leu,6 desGly10 ‐LHRH ethylamide monoacetate (LHRH agonist), was incorporated into small cylinders with these copolyesters. An initial burst of LHRH agonist was observed for cylinders prepared with parabolic‐type degrading copolyesters, in contrast to a marked delay in LHRH agonist release for cylinders prepared with S‐type degrading copolyesters. The resulting daily dose of drug was maintained an approximately constant, though decreasing stepwise with time. For example, the daily amount of LHRH agonist released in vivo from a cylinder prepared with poly(GA/CL) (50/50 mol%; Mn = 4500) was 61 ± 39 μg/day throughout an experimental period of 10 weeks with a corresponding pharmacological effect on the rat prostate.Keywords
This publication has 21 references indexed in Scilit:
- A new biodegradable pasty-type copolymer of l-lactic acid and δ-valerolactone with relatively low molecular weight for application in drug delivery systemsJournal of Controlled Release, 1989
- In vivo characteristics of low molecular weight copoly(D,L-lactic acid) formulations with controlled release of LH-RH agonistBiomaterials, 1989
- Living polymerization of .delta.-valerolactone with aluminum porphyrin: trimolecular mechanism by the participation of two aluminum porphyrin moleculesMacromolecules, 1987
- Polylactones. 1. Copolymerizations of glycolide and iε-caprolactoneMacromolecules, 1984
- Anionic polymerization of lactones initiated by alkali graphitides. III. Polymerization of δ-valerolactone initiated by KC24Journal of Polymer Science: Polymer Chemistry Edition, 1984
- Scanning electron microscopic study of the hydrolytic degradation of poly(glycolic acid) sutureJournal of Biomedical Materials Research, 1982
- Aliphatic polyesters. III. Molecular weight and molecular weight distribution in alcohol‐initiated polymerizations of ϵ‐caprolactoneJournal of Polymer Science: Polymer Chemistry Edition, 1982
- Aliphatic polyesters. I. The degradation of poly(ϵ‐caprolactone) in vivoJournal of Applied Polymer Science, 1981
- A new absorbable sutureJournal of Biomedical Materials Research, 1971
- Lactone polymers. III. Polymerization of ε‐caprolactoneJournal of Polymer Science Part A-1: Polymer Chemistry, 1969